Majed M. Abuhajir, MD
Institution
Christus Health
Physician Status
accepting new patients
diagnosis
Jayastu Senapati, MBBS, MD, DM
Institution
The University of Texas MD Anderson Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Anurag Singh, MD
Institution
The University of Kansas
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Graft Versus Host Disease (GVHD)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Singh completed his Internal Medicine Residency as well as his Hematology and Oncology Fellowship at the State University of New York Upstate Medical University. His clinical interests include mismatched donor stem cell transplantation , Hereditary predisposition to hematologic malignancies and Cellular therapies. His research interests include donor selection in stem cell transplantation, Transplantation for myeloid malignancies , GVHD prophylaxis and germline predisposition to Hematological malignancies
High Risk MDS - 2025 Kansas City Patient and Family Conference
Topic(s)
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
In this recording, Dr. Jesus Gonazlez Lugo discusses the diagnosis of High Risk MDS and the evolution to AML along with treatment options for patients. Recording includes the question-and-answer session.
Aplastic Anemia - 2025 Kansas City Patient and Family Conference
Topic(s)
Aplastic Anemia
Presenter(s)
Taha Bat, MD
In this recording, Dr. Taha Bat discusses the diagnosis of aplastic anemia along with treatment options for patients. Recording includes the question-and-answer session.
Cell-autonomous dysregulation of interferon signaling drives clonal expansion of SRSF2-mutant MDS stem/progenitor cells
Original Publication Date
Article Source
External Web Content
Key Points SRSF2 mutations blunt responsiveness of MDS cells to IFN stimulation and promote their clonal fitness by downregulating STAT1 expression Proteasome inhibition restores STAT1 protein level and sensitivity of SRSF2-mutant MDS cells to IFN, suggesting a new therapeutic…
March for Marrow: Walk for PNH NJ / NY
Join us in Verona Park, NJ on Sunday, September 28, 2025 for a day of remembrance and awareness in celebration of the 19th Annual Walk for PNH.
The Walk for PNH is the nation's largest event to raise awareness and funds for PNH education and research. This inspiring event calls on participants of all ages and abilities to join in the fight against PNH.
AAMDSIF Joins Coalition Urging the Administration to Preserve our Nation’s Newborn Screening Program
Original Publication Date
Article Source
Coalition Action
A coalition of 272 organizations signed a public letter to the Secretary, Department of Health and Human Services, addressing the decision to eliminate the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). While each state may add on additional…